VT
IBB icon

Volterra Technologies’s iShares Biotechnology ETF IBB Stock Holding History

Volterra Technologies’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.57M Buy
29,297
+16,475
+128% +$2.83M 0.8% 31
2026
Q1 		$2.16M Buy
+12,822
New +$2.19M 0.26% 95
2025
Q4 		– Sell
-13,495
Closed -$2.19M – 426
2025
Q3 		$1.95M Buy
+13,495
New +$1.84M 0.17% 125

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Volterra Technologies's IBB Position: Q2 2026 in Review

Volterra Technologies increased its iShares Biotechnology ETF (IBB) stake by 128% in Q2 2026, buying an estimated $2.83M and bringing the position to 29,297 shares worth $5.57M. The position accounts for 0.8% of the portfolio, ranked #31.

Volterra Technologies first reported a position in IBB in Q3 2025 and has held it in 3 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Volterra Technologies held 29,297 shares of iShares Biotechnology ETF worth $5.57M as of Q2 2026.
  • Volterra Technologies bought 16,475 iShares Biotechnology ETF shares in Q2 2026, an estimated $2.83M.
  • iShares Biotechnology ETF made up 0.8% of Volterra Technologies's portfolio in Q2 2026, its #31 holding.
  • Volterra Technologies first reported a position in iShares Biotechnology ETF in Q3 2025 and has held it in 3 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Volterra Technologies's 13F filing for Q2 2026, filed 14 Aug 2026.